Naltrexone HCL-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data
Report Summary
Naltrexone HCL-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Naltrexone HCL industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Naltrexone HCL 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Naltrexone HCL worldwide and market share by regions, with company and product introduction, position in the Naltrexone HCL market
Market status and development trend of Naltrexone HCL by types and applications
Cost and profit status of Naltrexone HCL, and marketing status
Market growth drivers and challenges
The report segments the global Naltrexone HCL market as:
Global Naltrexone HCL Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023)
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Naltrexone HCL Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Medical Grade
Other
Global Naltrexone HCL Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Opioid Independence
Alcohol Independence
Other
Global Naltrexone HCL Market: Manufacturers Segment Analysis (Company and Product introduction, Naltrexone HCL Sales Volume, Revenue, Price and Gross Margin):
Teva
Ascent Scientific
Adooq Bioscience
Mallinckrodt Pharmaceuticals
Sun Pharma
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Naltrexone HCL-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Naltrexone HCL industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Naltrexone HCL 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Naltrexone HCL worldwide and market share by regions, with company and product introduction, position in the Naltrexone HCL market
Market status and development trend of Naltrexone HCL by types and applications
Cost and profit status of Naltrexone HCL, and marketing status
Market growth drivers and challenges
The report segments the global Naltrexone HCL market as:
Global Naltrexone HCL Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023)
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Naltrexone HCL Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Medical Grade
Other
Global Naltrexone HCL Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Opioid Independence
Alcohol Independence
Other
Global Naltrexone HCL Market: Manufacturers Segment Analysis (Company and Product introduction, Naltrexone HCL Sales Volume, Revenue, Price and Gross Margin):
Teva
Ascent Scientific
Adooq Bioscience
Mallinckrodt Pharmaceuticals
Sun Pharma
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF NALTREXONE HCL
1.1 Definition of Naltrexone HCL in This Report
1.2 Commercial Types of Naltrexone HCL
1.2.1 Medical Grade
1.2.2 Other
1.3 Downstream Application of Naltrexone HCL
1.3.1 Opioid Independence
1.3.2 Alcohol Independence
1.3.3 Other
1.4 Development History of Naltrexone HCL
1.5 Market Status and Trend of Naltrexone HCL 2013-2023
1.5.1 Global Naltrexone HCL Market Status and Trend 2013-2023
1.5.2 Regional Naltrexone HCL Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Naltrexone HCL 2013-2017
2.2 Sales Market of Naltrexone HCL by Regions
2.2.1 Sales Volume of Naltrexone HCL by Regions
2.2.2 Sales Value of Naltrexone HCL by Regions
2.3 Production Market of Naltrexone HCL by Regions
2.4 Global Market Forecast of Naltrexone HCL 2018-2023
2.4.1 Global Market Forecast of Naltrexone HCL 2018-2023
2.4.2 Market Forecast of Naltrexone HCL by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Naltrexone HCL by Types
3.2 Sales Value of Naltrexone HCL by Types
3.3 Market Forecast of Naltrexone HCL by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Naltrexone HCL by Downstream Industry
4.2 Global Market Forecast of Naltrexone HCL by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Naltrexone HCL Market Status by Countries
5.1.1 North America Naltrexone HCL Sales by Countries (2013-2017)
5.1.2 North America Naltrexone HCL Revenue by Countries (2013-2017)
5.1.3 United States Naltrexone HCL Market Status (2013-2017)
5.1.4 Canada Naltrexone HCL Market Status (2013-2017)
5.1.5 Mexico Naltrexone HCL Market Status (2013-2017)
5.2 North America Naltrexone HCL Market Status by Manufacturers
5.3 North America Naltrexone HCL Market Status by Type (2013-2017)
5.3.1 North America Naltrexone HCL Sales by Type (2013-2017)
5.3.2 North America Naltrexone HCL Revenue by Type (2013-2017)
5.4 North America Naltrexone HCL Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Naltrexone HCL Market Status by Countries
6.1.1 Europe Naltrexone HCL Sales by Countries (2013-2017)
6.1.2 Europe Naltrexone HCL Revenue by Countries (2013-2017)
6.1.3 Germany Naltrexone HCL Market Status (2013-2017)
6.1.4 UK Naltrexone HCL Market Status (2013-2017)
6.1.5 France Naltrexone HCL Market Status (2013-2017)
6.1.6 Italy Naltrexone HCL Market Status (2013-2017)
6.1.7 Russia Naltrexone HCL Market Status (2013-2017)
6.1.8 Spain Naltrexone HCL Market Status (2013-2017)
6.1.9 Benelux Naltrexone HCL Market Status (2013-2017)
6.2 Europe Naltrexone HCL Market Status by Manufacturers
6.3 Europe Naltrexone HCL Market Status by Type (2013-2017)
6.3.1 Europe Naltrexone HCL Sales by Type (2013-2017)
6.3.2 Europe Naltrexone HCL Revenue by Type (2013-2017)
6.4 Europe Naltrexone HCL Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Naltrexone HCL Market Status by Countries
7.1.1 Asia Pacific Naltrexone HCL Sales by Countries (2013-2017)
7.1.2 Asia Pacific Naltrexone HCL Revenue by Countries (2013-2017)
7.1.3 China Naltrexone HCL Market Status (2013-2017)
7.1.4 Japan Naltrexone HCL Market Status (2013-2017)
7.1.5 India Naltrexone HCL Market Status (2013-2017)
7.1.6 Southeast Asia Naltrexone HCL Market Status (2013-2017)
7.1.7 Australia Naltrexone HCL Market Status (2013-2017)
7.2 Asia Pacific Naltrexone HCL Market Status by Manufacturers
7.3 Asia Pacific Naltrexone HCL Market Status by Type (2013-2017)
7.3.1 Asia Pacific Naltrexone HCL Sales by Type (2013-2017)
7.3.2 Asia Pacific Naltrexone HCL Revenue by Type (2013-2017)
7.4 Asia Pacific Naltrexone HCL Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Naltrexone HCL Market Status by Countries
8.1.1 Latin America Naltrexone HCL Sales by Countries (2013-2017)
8.1.2 Latin America Naltrexone HCL Revenue by Countries (2013-2017)
8.1.3 Brazil Naltrexone HCL Market Status (2013-2017)
8.1.4 Argentina Naltrexone HCL Market Status (2013-2017)
8.1.5 Colombia Naltrexone HCL Market Status (2013-2017)
8.2 Latin America Naltrexone HCL Market Status by Manufacturers
8.3 Latin America Naltrexone HCL Market Status by Type (2013-2017)
8.3.1 Latin America Naltrexone HCL Sales by Type (2013-2017)
8.3.2 Latin America Naltrexone HCL Revenue by Type (2013-2017)
8.4 Latin America Naltrexone HCL Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Naltrexone HCL Market Status by Countries
9.1.1 Middle East and Africa Naltrexone HCL Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Naltrexone HCL Revenue by Countries (2013-2017)
9.1.3 Middle East Naltrexone HCL Market Status (2013-2017)
9.1.4 Africa Naltrexone HCL Market Status (2013-2017)
9.2 Middle East and Africa Naltrexone HCL Market Status by Manufacturers
9.3 Middle East and Africa Naltrexone HCL Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Naltrexone HCL Sales by Type (2013-2017)
9.3.2 Middle East and Africa Naltrexone HCL Revenue by Type (2013-2017)
9.4 Middle East and Africa Naltrexone HCL Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF NALTREXONE HCL
10.1 Global Economy Situation and Trend Overview
10.2 Naltrexone HCL Downstream Industry Situation and Trend Overview
CHAPTER 11 NALTREXONE HCL MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Naltrexone HCL by Major Manufacturers
11.2 Production Value of Naltrexone HCL by Major Manufacturers
11.3 Basic Information of Naltrexone HCL by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Naltrexone HCL Major Manufacturer
11.3.2 Employees and Revenue Level of Naltrexone HCL Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 NALTREXONE HCL MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Teva
12.1.1 Company profile
12.1.2 Representative Naltrexone HCL Product
12.1.3 Naltrexone HCL Sales, Revenue, Price and Gross Margin of Teva
12.2 Ascent Scientific
12.2.1 Company profile
12.2.2 Representative Naltrexone HCL Product
12.2.3 Naltrexone HCL Sales, Revenue, Price and Gross Margin of Ascent Scientific
12.3 Adooq Bioscience
12.3.1 Company profile
12.3.2 Representative Naltrexone HCL Product
12.3.3 Naltrexone HCL Sales, Revenue, Price and Gross Margin of Adooq Bioscience
12.4 Mallinckrodt Pharmaceuticals
12.4.1 Company profile
12.4.2 Representative Naltrexone HCL Product
12.4.3 Naltrexone HCL Sales, Revenue, Price and Gross Margin of Mallinckrodt Pharmaceuticals
12.5 Sun Pharma
12.5.1 Company profile
12.5.2 Representative Naltrexone HCL Product
12.5.3 Naltrexone HCL Sales, Revenue, Price and Gross Margin of Sun Pharma
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF NALTREXONE HCL
13.1 Industry Chain of Naltrexone HCL
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF NALTREXONE HCL
14.1 Cost Structure Analysis of Naltrexone HCL
14.2 Raw Materials Cost Analysis of Naltrexone HCL
14.3 Labor Cost Analysis of Naltrexone HCL
14.4 Manufacturing Expenses Analysis of Naltrexone HCL
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Naltrexone HCL in This Report
1.2 Commercial Types of Naltrexone HCL
1.2.1 Medical Grade
1.2.2 Other
1.3 Downstream Application of Naltrexone HCL
1.3.1 Opioid Independence
1.3.2 Alcohol Independence
1.3.3 Other
1.4 Development History of Naltrexone HCL
1.5 Market Status and Trend of Naltrexone HCL 2013-2023
1.5.1 Global Naltrexone HCL Market Status and Trend 2013-2023
1.5.2 Regional Naltrexone HCL Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Naltrexone HCL 2013-2017
2.2 Sales Market of Naltrexone HCL by Regions
2.2.1 Sales Volume of Naltrexone HCL by Regions
2.2.2 Sales Value of Naltrexone HCL by Regions
2.3 Production Market of Naltrexone HCL by Regions
2.4 Global Market Forecast of Naltrexone HCL 2018-2023
2.4.1 Global Market Forecast of Naltrexone HCL 2018-2023
2.4.2 Market Forecast of Naltrexone HCL by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Naltrexone HCL by Types
3.2 Sales Value of Naltrexone HCL by Types
3.3 Market Forecast of Naltrexone HCL by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Naltrexone HCL by Downstream Industry
4.2 Global Market Forecast of Naltrexone HCL by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Naltrexone HCL Market Status by Countries
5.1.1 North America Naltrexone HCL Sales by Countries (2013-2017)
5.1.2 North America Naltrexone HCL Revenue by Countries (2013-2017)
5.1.3 United States Naltrexone HCL Market Status (2013-2017)
5.1.4 Canada Naltrexone HCL Market Status (2013-2017)
5.1.5 Mexico Naltrexone HCL Market Status (2013-2017)
5.2 North America Naltrexone HCL Market Status by Manufacturers
5.3 North America Naltrexone HCL Market Status by Type (2013-2017)
5.3.1 North America Naltrexone HCL Sales by Type (2013-2017)
5.3.2 North America Naltrexone HCL Revenue by Type (2013-2017)
5.4 North America Naltrexone HCL Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Naltrexone HCL Market Status by Countries
6.1.1 Europe Naltrexone HCL Sales by Countries (2013-2017)
6.1.2 Europe Naltrexone HCL Revenue by Countries (2013-2017)
6.1.3 Germany Naltrexone HCL Market Status (2013-2017)
6.1.4 UK Naltrexone HCL Market Status (2013-2017)
6.1.5 France Naltrexone HCL Market Status (2013-2017)
6.1.6 Italy Naltrexone HCL Market Status (2013-2017)
6.1.7 Russia Naltrexone HCL Market Status (2013-2017)
6.1.8 Spain Naltrexone HCL Market Status (2013-2017)
6.1.9 Benelux Naltrexone HCL Market Status (2013-2017)
6.2 Europe Naltrexone HCL Market Status by Manufacturers
6.3 Europe Naltrexone HCL Market Status by Type (2013-2017)
6.3.1 Europe Naltrexone HCL Sales by Type (2013-2017)
6.3.2 Europe Naltrexone HCL Revenue by Type (2013-2017)
6.4 Europe Naltrexone HCL Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Naltrexone HCL Market Status by Countries
7.1.1 Asia Pacific Naltrexone HCL Sales by Countries (2013-2017)
7.1.2 Asia Pacific Naltrexone HCL Revenue by Countries (2013-2017)
7.1.3 China Naltrexone HCL Market Status (2013-2017)
7.1.4 Japan Naltrexone HCL Market Status (2013-2017)
7.1.5 India Naltrexone HCL Market Status (2013-2017)
7.1.6 Southeast Asia Naltrexone HCL Market Status (2013-2017)
7.1.7 Australia Naltrexone HCL Market Status (2013-2017)
7.2 Asia Pacific Naltrexone HCL Market Status by Manufacturers
7.3 Asia Pacific Naltrexone HCL Market Status by Type (2013-2017)
7.3.1 Asia Pacific Naltrexone HCL Sales by Type (2013-2017)
7.3.2 Asia Pacific Naltrexone HCL Revenue by Type (2013-2017)
7.4 Asia Pacific Naltrexone HCL Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Naltrexone HCL Market Status by Countries
8.1.1 Latin America Naltrexone HCL Sales by Countries (2013-2017)
8.1.2 Latin America Naltrexone HCL Revenue by Countries (2013-2017)
8.1.3 Brazil Naltrexone HCL Market Status (2013-2017)
8.1.4 Argentina Naltrexone HCL Market Status (2013-2017)
8.1.5 Colombia Naltrexone HCL Market Status (2013-2017)
8.2 Latin America Naltrexone HCL Market Status by Manufacturers
8.3 Latin America Naltrexone HCL Market Status by Type (2013-2017)
8.3.1 Latin America Naltrexone HCL Sales by Type (2013-2017)
8.3.2 Latin America Naltrexone HCL Revenue by Type (2013-2017)
8.4 Latin America Naltrexone HCL Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Naltrexone HCL Market Status by Countries
9.1.1 Middle East and Africa Naltrexone HCL Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Naltrexone HCL Revenue by Countries (2013-2017)
9.1.3 Middle East Naltrexone HCL Market Status (2013-2017)
9.1.4 Africa Naltrexone HCL Market Status (2013-2017)
9.2 Middle East and Africa Naltrexone HCL Market Status by Manufacturers
9.3 Middle East and Africa Naltrexone HCL Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Naltrexone HCL Sales by Type (2013-2017)
9.3.2 Middle East and Africa Naltrexone HCL Revenue by Type (2013-2017)
9.4 Middle East and Africa Naltrexone HCL Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF NALTREXONE HCL
10.1 Global Economy Situation and Trend Overview
10.2 Naltrexone HCL Downstream Industry Situation and Trend Overview
CHAPTER 11 NALTREXONE HCL MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Naltrexone HCL by Major Manufacturers
11.2 Production Value of Naltrexone HCL by Major Manufacturers
11.3 Basic Information of Naltrexone HCL by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Naltrexone HCL Major Manufacturer
11.3.2 Employees and Revenue Level of Naltrexone HCL Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 NALTREXONE HCL MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Teva
12.1.1 Company profile
12.1.2 Representative Naltrexone HCL Product
12.1.3 Naltrexone HCL Sales, Revenue, Price and Gross Margin of Teva
12.2 Ascent Scientific
12.2.1 Company profile
12.2.2 Representative Naltrexone HCL Product
12.2.3 Naltrexone HCL Sales, Revenue, Price and Gross Margin of Ascent Scientific
12.3 Adooq Bioscience
12.3.1 Company profile
12.3.2 Representative Naltrexone HCL Product
12.3.3 Naltrexone HCL Sales, Revenue, Price and Gross Margin of Adooq Bioscience
12.4 Mallinckrodt Pharmaceuticals
12.4.1 Company profile
12.4.2 Representative Naltrexone HCL Product
12.4.3 Naltrexone HCL Sales, Revenue, Price and Gross Margin of Mallinckrodt Pharmaceuticals
12.5 Sun Pharma
12.5.1 Company profile
12.5.2 Representative Naltrexone HCL Product
12.5.3 Naltrexone HCL Sales, Revenue, Price and Gross Margin of Sun Pharma
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF NALTREXONE HCL
13.1 Industry Chain of Naltrexone HCL
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF NALTREXONE HCL
14.1 Cost Structure Analysis of Naltrexone HCL
14.2 Raw Materials Cost Analysis of Naltrexone HCL
14.3 Labor Cost Analysis of Naltrexone HCL
14.4 Manufacturing Expenses Analysis of Naltrexone HCL
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
